enVVeno Medical Corp(NVNO)Stock Analysis

NVNO Stock Analysis & AI Quality Score

AI stock analysis and institutional research for enVVeno Medical Corp (NVNO), a Healthcare sector company. NVNO is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.4m in revenue. Based on the latest XBRL financial filings (Q1 2026), enVVeno Medical Corp reports net income of $-3.8M, free cash flow of $-3.2M. Top institutional holders of NVNO by reported 13-F value include KINGDON CAPITAL MANAGEMENT, L.L.C., CM Management,, GEODE CAPITAL MANAGEMENT,, based on the most recent SEC filings. NVNO trades on the Nasdaq exchange and files with the SEC under CIK 1661053. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NVNO daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for enVVeno Medical Corp directly from SEC EDGAR.